Layton Bioecience is a Biotechnology Pharmaceutical with primary focus to Therapeutics Diagnostics . The firm has expertise in the fields of Human neuronal cells for transplantation in patients with neurodegenerative diseases such as stroke, Parkinson's and Huntington's disease, spinal cord injury, and neurodegenerative eye diseases; in Nicotinic acetycholoine receptor antagonists for neuropsychiatric and movement disorders such as Tourette Syndrome, attention deficit disorder, and bipolar disease; in Methane sulfonal fluoride for Alzheimer's disease; in Corticotropin-release inhibiting factor for stress related diseases; and In situ transcription and aRNA amplification for use in genetic screening and as a human diagnostic platform technology.
